Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant

Earlier studies with montelukast (M) and telmisartan (T) have revealed their potential antiviral properties against SARS-CoV-2 wild-type (WT) but have not assessed their efficacy against emerging Variants of Concern (VOCs) such as Omicron. Our research fills this gap by investigating these drugs...

Full description

Saved in:
Bibliographic Details
Main Authors: Nirmitee Mulgaonkar (Author), Haoqi Wang (Author), Junrui Zhang (Author), Christopher M. Roundy (Author), Wendy Tang (Author), Sankar Prasad Chaki (Author), Alex Pauvolid-Corrêa (Author), Gabriel L. Hamer (Author), Sandun Fernando (Author)
Format: Book
Published: MDPI AG, 2023-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available